Kennedy Capital Management LLC Takes Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Kennedy Capital Management LLC acquired a new stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 6,378 shares of the medical equipment provider’s stock, valued at approximately $2,545,000.

Several other institutional investors and hedge funds have also bought and sold shares of the company. Loring Wolcott & Coolidge Fiduciary Advisors LLP MA raised its position in shares of Intuitive Surgical by 0.3% in the fourth quarter. Loring Wolcott & Coolidge Fiduciary Advisors LLP MA now owns 8,899 shares of the medical equipment provider’s stock worth $3,002,000 after buying an additional 27 shares in the last quarter. Advance Capital Management Inc. raised its position in shares of Intuitive Surgical by 3.8% in the first quarter. Advance Capital Management Inc. now owns 740 shares of the medical equipment provider’s stock worth $295,000 after buying an additional 27 shares in the last quarter. Perigon Wealth Management LLC raised its position in shares of Intuitive Surgical by 0.5% in the first quarter. Perigon Wealth Management LLC now owns 5,363 shares of the medical equipment provider’s stock worth $2,140,000 after buying an additional 27 shares in the last quarter. Sugarloaf Wealth Management LLC raised its position in shares of Intuitive Surgical by 5.7% in the first quarter. Sugarloaf Wealth Management LLC now owns 534 shares of the medical equipment provider’s stock worth $213,000 after buying an additional 29 shares in the last quarter. Finally, Sheaff Brock Investment Advisors LLC raised its position in Intuitive Surgical by 1.3% during the fourth quarter. Sheaff Brock Investment Advisors LLC now owns 2,226 shares of the medical equipment provider’s stock valued at $751,000 after purchasing an additional 29 shares in the last quarter. 83.64% of the stock is owned by institutional investors.

Intuitive Surgical Stock Up 2.7 %

ISRG traded up $11.89 during mid-day trading on Wednesday, reaching $444.58. 339,453 shares of the company traded hands, compared to its average volume of 1,550,501. Intuitive Surgical, Inc. has a 52-week low of $254.85 and a 52-week high of $468.78. The company’s fifty day moving average price is $429.30 and its 200-day moving average price is $399.85. The stock has a market capitalization of $157.98 billion, a P/E ratio of 78.30, a P/E/G ratio of 4.89 and a beta of 1.39.

Intuitive Surgical (NASDAQ:ISRG) last issued its quarterly earnings data on Thursday, July 18th. The medical equipment provider reported $1.78 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.54 by $0.24. Intuitive Surgical had a net margin of 27.65% and a return on equity of 13.04%. The firm had revenue of $2.01 billion during the quarter, compared to the consensus estimate of $1.97 billion. During the same quarter in the previous year, the firm posted $1.18 EPS. The company’s revenue for the quarter was up 14.5% compared to the same quarter last year. As a group, sell-side analysts forecast that Intuitive Surgical, Inc. will post 5.22 earnings per share for the current fiscal year.

Analyst Ratings Changes

A number of research firms have weighed in on ISRG. Morgan Stanley raised their price target on Intuitive Surgical from $375.00 to $460.00 and gave the company an “equal weight” rating in a research report on Monday, July 15th. Truist Financial raised their price target on Intuitive Surgical from $450.00 to $515.00 and gave the company a “buy” rating in a research report on Tuesday, July 16th. Citigroup lifted their price objective on Intuitive Surgical from $462.00 to $512.00 and gave the stock a “buy” rating in a report on Wednesday, July 10th. The Goldman Sachs Group began coverage on Intuitive Surgical in a report on Thursday, May 30th. They issued a “buy” rating and a $500.00 price objective on the stock. Finally, Robert W. Baird lifted their price objective on Intuitive Surgical from $487.00 to $503.00 and gave the stock an “outperform” rating in a report on Friday, July 19th. Six research analysts have rated the stock with a hold rating and fourteen have given a buy rating to the stock. Based on data from MarketBeat.com, Intuitive Surgical currently has an average rating of “Moderate Buy” and an average price target of $438.74.

Insiders Place Their Bets

In other Intuitive Surgical news, Director Craig H. Barratt sold 2,496 shares of the stock in a transaction on Monday, June 3rd. The stock was sold at an average price of $402.89, for a total value of $1,005,613.44. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. In other Intuitive Surgical news, Director Craig H. Barratt sold 2,496 shares of the stock in a transaction on Monday, June 3rd. The stock was sold at an average price of $402.89, for a total value of $1,005,613.44. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, insider Gary S. Guthart 7,440 shares of the stock in a transaction that occurred on Tuesday, July 30th. The disclosure for this trade can be found here. In the last quarter, insiders sold 14,771 shares of company stock worth $6,239,210. Corporate insiders own 0.90% of the company’s stock.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.